Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-05-13 Purchase |
2021-05-17 09:22 am |
Eloxx Pharmaceuticals Inc. | ELOX | PAREKH RAJESH B Director |
2,466,666 | $1.35 | $3,329,999 | 4,827,129 (Indirect) |
View |
| 2021-05-13 Purchase |
2021-05-17 07:03 am |
Eloxx Pharmaceuticals Inc. | ELOX | Pontifax Management 4 G.P. (2015) Ltd. Pontifax (China) IV L.P. Pontifax (Cayman) IV L.P. Pontifax (Israel) IV L.P. Pontifax IV GP L.P. 10% Owner |
5,925,925 | $1.35 | $7,999,999 | 616,592 (Indirect) |
View |
| 2021-05-13 Purchase |
2021-05-17 07:02 am |
Eloxx Pharmaceuticals Inc. | ELOX | Nussbaum Ran Director |
5,925,925 | $1.35 | $7,999,999 | 7,804,778 (Indirect) |
View |
| 2021-05-13 Purchase |
2021-05-17 07:00 am |
Eloxx Pharmaceuticals Inc. | ELOX | Kariv Tomer Director |
5,925,925 | $1.35 | $7,999,999 | 7,804,778 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-05-19 Option Award |
2021-05-20 4:10 pm |
N/A 2031-05-19 |
Eloxx Pharmaceuticals Inc. | ELOX | Rubin Steven D Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-05-19 Option Award |
2021-05-20 4:10 pm |
N/A 2031-05-19 |
Eloxx Pharmaceuticals Inc. | ELOX | Seehra Jasbir Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-05-18 Option Award |
2021-05-18 5:48 pm |
N/A 2031-04-01 |
Eloxx Pharmaceuticals Inc. | ELOX | MODUR VIJAY HEAD OF R&D |
496,204 | $0 | 496,204 (Direct) |
View |
| 2021-05-18 Option Award |
2021-05-18 5:45 pm |
N/A 2031-04-01 |
Eloxx Pharmaceuticals Inc. | ELOX | Aggarwal Sumit PRESIDENT AND CEO |
992,409 | $0 | 992,409 (Direct) |
View |
| 2021-04-30 Tax Withholding |
2021-05-03 10:15 am |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC |
459 | $2.18 | 38,118 (Direct) |
View |
| 2021-04-30 Exercise |
2021-05-03 10:15 am |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC |
1,562 | $0 | 38,118 (Direct) |
View |
| 2021-04-20 Option Award |
2021-04-22 11:55 am |
N/A 2026-04-20 |
Eloxx Pharmaceuticals Inc. | ELOX | Geffken Daniel E. CHIEF FINANCIAL OFFICER |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-05 8:33 pm |
N/A 2031-04-01 |
Eloxx Pharmaceuticals Inc. | ELOX | PAREKH RAJESH B Director |
2,572,270 | $0 | 2,485,239 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-02 9:04 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Walts Alan Edmund Director |
77,695 | $0 | 77,695 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-02 9:00 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | MODUR VIJAY HEAD OF R&D |
930,945 | $0 | 1,105,588 (Direct) |
View |
| 2021-04-01 Option Award |
2021-04-02 8:55 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Aggarwal Sumit PRESIDENT AND CEO |
1,702,396 | $0 | 1,925,700 (Direct) |
View |
Ownership |
2021-03-26 8:50 pm |
N/A 2030-01-21 |
Eloxx Pharmaceuticals Inc. | ELOX | Rakers Gary D. Controller, PFO/PAO, Treasurer |
0 | $0 | 42,225 (Direct) |
View |
| 2021-02-25 Tax Withholding |
2021-02-26 7:05 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC |
7,338 | $3.95 | 101,077 (Direct) |
View |
| 2021-02-25 Exercise |
2021-02-26 7:05 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC |
25,000 | $0 | 101,077 (Direct) |
View |
| 2021-02-25 Tax Withholding |
2021-02-26 7:05 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CHIEF EXECUTIVE OFFICER |
15,360 | $3.95 | 194,629 (Direct) |
View |
| 2021-02-25 Exercise |
2021-02-26 7:05 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CHIEF EXECUTIVE OFFICER |
50,000 | $0 | 194,629 (Direct) |
View |
| 2021-02-12 Option Award |
2021-02-17 6:43 pm |
N/A 2031-02-12 |
Eloxx Pharmaceuticals Inc. | ELOX | MacDonald Stephen G. VP FINANCE & ACCTG, TREASURER |
18,849 | $0 | 18,849 (Direct) |
View |
| 2021-02-12 Option Award |
2021-02-17 6:40 pm |
N/A 2031-02-12 |
Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC |
120,000 | $0 | 120,000 (Direct) |
View |
| 2021-02-12 Option Award |
2021-02-17 6:38 pm |
N/A 2031-02-12 |
Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CHIEF EXECUTIVE OFFICER |
300,000 | $0 | 300,000 (Direct) |
View |
| 2021-01-30 Tax Withholding |
2021-02-02 4:10 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC |
542 | $3.44 | 20,915 (Direct) |
View |
| 2021-01-30 Exercise |
2021-02-02 4:10 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC |
1,563 | $0 | 20,915 (Direct) |
View |
| 2021-01-30 Tax Withholding |
2021-02-02 4:10 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CHIEF EXECUTIVE OFFICER |
643 | $3.44 | 24,989 (Direct) |
View |
| 2021-01-30 Exercise |
2021-02-02 4:10 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CHIEF EXECUTIVE OFFICER |
1,875 | $0 | 24,989 (Direct) |
View |
| 2020-10-30 Tax Withholding |
2020-11-02 4:20 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CHIEF EXECUTIVE OFFICER |
625 | $2.53 | 25,632 (Direct) |
View |
| 2020-10-30 Exercise |
2020-11-02 4:20 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CHIEF EXECUTIVE OFFICER |
1,875 | $0 | 25,632 (Direct) |
View |
| 2020-10-30 Tax Withholding |
2020-11-02 4:20 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC |
459 | $2.53 | 21,457 (Direct) |
View |
| 2020-10-30 Exercise |
2020-11-02 4:20 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC |
1,562 | $0 | 21,457 (Direct) |
View |
| 2020-07-30 Tax Withholding |
2020-07-31 4:10 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC |
459 | $2.84 | 21,916 (Direct) |
View |
| 2020-07-30 Exercise |
2020-07-31 4:10 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Belloff Neil S. COO, GENERAL COUNSEL &CORP SEC |
1,563 | $0 | 21,916 (Direct) |
View |
| 2020-07-30 Tax Withholding |
2020-07-31 4:10 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CHIEF EXECUTIVE OFFICER |
576 | $2.84 | 26,257 (Direct) |
View |
| 2020-07-30 Exercise |
2020-07-31 4:10 pm |
N/A N/A |
Eloxx Pharmaceuticals Inc. | ELOX | Williams Gregory C. CHIEF EXECUTIVE OFFICER |
1,875 | $0 | 26,257 (Direct) |
View |
| 2020-05-20 Option Award |
2020-05-26 3:03 pm |
N/A 2030-05-20 |
Eloxx Pharmaceuticals Inc. | ELOX | Rubin Steven D Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-05-20 Option Award |
2020-05-22 4:10 pm |
N/A 2030-05-20 |
Eloxx Pharmaceuticals Inc. | ELOX | Pontifax Management 4 G.P. (2015) Ltd. Pontifax IV GP L.P. Pontifax (Cayman) IV L.P. Pontifax (China) IV L.P. Pontifax (Israel) IV L.P. Pontifax Management III G.P. (2011) Ltd. Pontifax Management Fund III L.P. Pontifax (Cayman) III L.P. Pontifax (Israel) III L.P. 10% Owner |
40,000 | $0 | 40,000 (Indirect) |
View |
| 2020-05-20 Option Award |
2020-05-22 4:10 pm |
N/A 2030-05-20 |
Eloxx Pharmaceuticals Inc. | ELOX | Seehra Jasbir Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-05-20 Option Award |
2020-05-22 4:10 pm |
N/A 2030-05-20 |
Eloxx Pharmaceuticals Inc. | ELOX | Veinrib Gadi Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-05-20 Option Award |
2020-05-22 4:10 pm |
N/A 2030-05-20 |
Eloxx Pharmaceuticals Inc. | ELOX | Kariv Tomer Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-05-20 Option Award |
2020-05-22 4:10 pm |
N/A 2030-05-20 |
Eloxx Pharmaceuticals Inc. | ELOX | Avnur Zafrira Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-05-20 Option Award |
2020-05-22 4:10 pm |
N/A 2030-05-20 |
Eloxx Pharmaceuticals Inc. | ELOX | Noiman Silvia Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-05-20 Option Award |
2020-05-22 4:10 pm |
N/A 2030-05-20 |
Eloxx Pharmaceuticals Inc. | ELOX | Nussbaum Ran Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2020-05-20 Option Award |
2020-05-22 4:10 pm |
N/A 2030-05-20 |
Eloxx Pharmaceuticals Inc. | ELOX | Kleijwegt Martijn Director |
20,000 | $0 | 20,000 (Direct) |
View |